ASCO Partners With FDA to Incorporate Real-World Evidence into Drug Decisions

June 9, 2017 – In recognition of the potential for real-world evidence (RWE) to significantly improve the way patients with cancer are treated, CancerLinQ has formed new partnerships with the US government that are expected to coordinate the sharing of patient data and incorporate that information into the FDA regulatory process. CancerLinQ is a subsidiary created by ASCO to extrapolate treatment insights from the vast amounts of oncology treatment data being .. (leggi tutto)